Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT05232292

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Samara Regional Cardiology Dispensary (from the registry)
Registry
  • NCT NCT05232292
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05232292. Randomized; no masking; primary purpose prevention. Start 2021-10-06 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure
Acronym
IV-ACS&CHF
Condition
Acute Coronary Syndrome
Condition
Chronic Heart Failure
Intervention (Biological)
Ultrix Quadri
Lead sponsor
Samara Regional Cardiology Dispensary (class: other)

Record details

Record id
cardio:ct-nct05232292
Content hash
661e7b65359628b2506375749995119a6ce4a875f7ea63cc3b634ab623722c8b